Adjuvant chemotherapy in gastric cancer: A meta-analysis of randomized trials and a comparison with previous meta-analyses

Tumori

Volumn 88, Issue 1, 2002, Pages 21-27

  Panzini, Ilaria ^a   Gianni, Lorenzo ^a   Fattori, Pier Paolo ^a   Tassinari, Davide ^a   Imola, Manuela ^a   Fabbri, Paolo ^a   Arcangeli, Valentina ^a   Drudi, Giuliana ^a   Canuti, Debora ^a   Fochessati, Francesca ^a   Ravaioli, Alberto ^a  

^a Ospedale Infermi   (Italy)

Author keywords

Adjuvant chemotherapy; Gastric cancer; Meta analysis; Randomized controlled trials

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; PLATINUM; SEMUSTINE; TEGAFUR; UFT; VINBLASTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; PATIENT SELECTION; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; HUMANS; IMMUNOTHERAPY; ODDS RATIO; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036203559     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Global cancer statistics
2. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study
3. Surgical results in gastric cancer
4. ECF in gastric cancer
5. Epirubicin, cisplatin, and continous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer
6. Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: An effective chemotherapy in advanced gastric cancer
7. Long term survival after epirubicin, cisplatin and fluorouracil for gastric cancer
8. Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: Experience with treatment schedules incorporating intravenous and oral etoposide
9. Adjuvant therapy for gastric carcinoma: Closing out the century
10. Adjuvant therapy for gastric carcinoma patients in the past 15 years. A review of Western and Oriental trials
11. Curing gastric cancer-hone the scalpel with magic?
12. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials
13. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials
14. Efficacy of adjuvant chemotherapy after curative resections for gastric cancer: A meta-analysis of published randomized trials
15. In reply
16. Assessing the quality of RCTs: Why, what, how and by whom?
17. Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer
18. Overview of randomized trials of diuretics in pregnancy
19. Beta blockade during and after myocardial infartion: An overview of the randomized trials
20. Meta-analysis in clinical research
21. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of non surgical treatment
22. Gastric cancer: A controlled trial of adjuvant chemotherapy following gastrectomy
23. Randomly controlled study of chemotherapy versus chemo-immunotherapy in post-operative gastric cancer patients
24. A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients
25. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group
26. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report
27. Adjuvant chemotherapy in operable gastric cancer. 5 Years follow-up of first British Stomach Cancer Group trial
28. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up
29. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the Gastrointestinal Tract Cancer Cooperative Group of the EORTC
30. Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-Year results of a prospective randomized study
31. The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-Year results of a prospective randomized trial
32. A randomized clinical trial of adjuvant chemotherapy after resection in patients with stomach cancer
33. Mitomycin C as an adjuvant in resected gastric cancer
34. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up
35. Positive results of adjuvant mitomycin-C in resected gastric cancer: A randomised trial on 134 patients
36. Gastric carcinoma treated by chemotherapy after resection: A controlled study
37. Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-Year results
38. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer
39. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology Group report
40. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer
41. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275)
42. Adjuvant treatments following curative resection for gastric cancer
43. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer
44. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
45. Adjuvant chemotherapy for resectable gastric cancer: A preliminary report
46. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer
47. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study
48. Adjuvant chemotherapy after gastric resection in node-positive cancer patients: A multicentre randomised study
49. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer
50. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer
51. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomised trial
52. Meta-analysis of adjuvant chemotherapy in gastric cancer: A critical reappraisal
53. Meta-analyses need time, collaboration and funding
54. In reply
55. A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer
56. Immunochemosurgery as a new approach to reasonable treatment of advanced cancer
57. Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: Results of a randomized trial
58. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
59. Large trials vs meta-analysis of smaller trials: How do their results compare
60. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. Results of Intergroup INT-0116 (SWOG-9008)
61. Chemotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
62. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116
63. Phase III study af adjuvant chemotherapy versus surgery alone in radically resected gastric cancer. Five year results of randomized study